Maryjane Farr joined the UT Southwestern Medical Center in September 2021, as Professor of Medicine and Section Chief of Heart Failure, Mechanical Circulatory Support and Transplant.  Previously she was the Irene and Sidney B. Silverman Associate Professor of Medicine and Medical Director of the Adult Heart Transplant Program at Columbia University Irving Medical Center.  Dr. Farr is a graduate of Barnard College, Columbia University (BA'89), Columbia College of Physicians & Surgeons, AOA ('98) and the Columbia Mailman School of Public Health (MSc'12).  Dr. Farr trained in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant at the New York Presbyterian Hospital and joined the staff in 2005.  

Dr. Farr was Director of Clinical Trials in Heart Failure and Transplant at Columbia from 2007-12, received an NIH training grant for her Master's degree from 2010-12 and was awarded the Shorin Silverstein Research in Transplant Award (at Columbia) for 2012-14.  

Dr. Farr directed the Columbia Adult Heart Transplant Program for 6 years, and during her 14 years on the team participated in the management of nearly 1000 new heart transplant recipients.  She has authored more than 100 peer-reviewed manuscripts in the field of heart failure, mechanical circulatory support or transplant.  She has participated in scholarly work and education with the ACC, AHA, HFSA, ISHLT and AST.  She has been an active member and leader at UNOS/OPTN on the Thoracic Committee, as Heart Subcommittee Chair, on the Membership and Professional Standards Committee, as Region 9 (New York) Associate Councilor and was recently appointed to the UNOS/OPTN Board of Directors (2021).  She is the Chair of the Conflict of Interest Committee for the ISHLT, and she is an Associate Editor of Transplantation and Content Editor at Circulation.  Her key areas of interest are on organ allocation, primary graft failure, complications of mechanical circulatory support as bridge to transplant and overall survival of patients with advanced heart failure.  


Medical School
Columbia University College of Physicians and Surgeons (1998)
New York Presbyterian Hospital/Weill Cornell Medical College (2001), Internal Medicine
New York Presbyterian Hospital/Weill Cornell Medical College (2004), Cardiovascular Disease
Graduate School
Columbia University Mailman School of Public Health (2011), Biostatistics


Featured Publications LegendFeatured Publications

Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
Grubb CS, Truby LK, Topkara VK, Bohnen MS, Yuzefpolskaya M, DeFilippis EM, Kleet A, Nakagawa S, Haythe JH, Axsom K, Colombo P, Takeda K, Uriel N, Sayer G, Garan H, Naka Y, Farr M, Am Heart J 2021 09 239 11-18
Outcomes of Heart Transplantation in Adult Congenital Heart Disease With Prior Intracardiac Repair.
Kainuma A, Sanchez J, Ning Y, Kurlansky PA, Axsom K, Farr M, Sayer G, Uriel N, Takayama H, Naka Y, Takeda K, Ann Thorac Surg 2021 09 112 3 846-853
Plasma kallikrein predicts primary graft dysfunction after heart transplant.
Giangreco NP, Lebreton G, Restaino S, Jane Farr M, Zorn E, Colombo PC, Patel J, Levine R, Truby L, Soni RK, Leprince P, Kobashigawa J, Tatonetti NP, Fine BM, J Heart Lung Transplant 2021 Jul
Consensus conference on heart-kidney transplantation.
Kobashigawa J, Dadhania DM, Farr M, Tang WHW, Bhimaraj A, Czer L, Hall S, Haririan A, Formica RN, Patel J, Skorka R, Fedson S, Srinivas T, Testani J, Yabu JM, Cheng XS, Am J Transplant 2021 07 21 7 2459-2467
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment.
Slomovich S, Bell J, Clerkin KJ, Habal MV, Griffin JM, Raikhelkar JK, Fried JA, Vossoughi SR, Finnigan K, Latif F, Farr MA, Sayer GT, Uriel N, Clin Transplant 2021 07 35 7 e14333
Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?
Topkara VK, Clerkin KJ, Fried JA, Griffin J, Raikhelkar J, Hi Lee S, Latif F, Habal M, Horn E, Farr MA, Takada K, Naka Y, Jorde UP, Sayer G, Uriel N, Circ Heart Fail 2021 Jun 14 6 e007916
Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.
Burack D, Pereira MR, Tsapepas DS, Harren P, Farr MA, Arcasoy S, Cohen DJ, Mohan S, Emond JC, Hod EA, Verna EC, Am J Transplant 2021 06 21 6 2254-2261
Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.
Pereira MR, Arcasoy S, Farr MA, Mohan S, Emond JC, Tsapepas DS, Shi Q, Purpura L, Uhlemann AC, Zucker J, Verna EC, Transpl Infect Dis 2021 May e13637
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy.
Habal MV, Miller AMI, Rao S, Lin S, Obradovic A, Khosravi-Maharlooei M, See SB, Roy P, Shihab R, Ho SH, Marboe CC, Naka Y, Takeda K, Restaino S, Han A, Mancini D, Givertz M, Madsen JC, Sykes M, Addonizio LJ, Farr MA, Zorn E, Am J Transplant 2021 04 21 4 1465-1476
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD, Am J Transplant 2021 02 21 2 475-483

Professional Associations/Affiliations

  • Circulation (2021)
  • International Heart and Lung Transplant (2021)
  • Transplantation (2021)
  • UNOS/OPTN Board of Directors (2021)
  • New York State Certificate of Need Committee (2019)